Lv4
790 积分 2022-01-24 加入
Biomarkers as Surrogate Endpoints in Drug Development: Finding Their Right Place
10天前
已完结
mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives
17天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
1个月前
已完结
Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins
2个月前
已完结
AI-driven biomarkers for antibody-drug conjugates
2个月前
已完结
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
3个月前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
3个月前
已完结
Assessment of Dendrigrafts of Poly-l-lysine Cytotoxicity and Cell Penetration in Cancer Cells
5个月前
已完结
Multiplex digital PCR for the simultaneous quantification of a miRNA panel
5个月前
已完结
皖公网安备34019202002308
